Cargando…
Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia
OBJECTIVE: Morphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study was to describe pharmacokinetics of morphine and...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375702/ https://www.ncbi.nlm.nih.gov/pubmed/30763356 http://dx.doi.org/10.1371/journal.pone.0211910 |
_version_ | 1783395414994583552 |
---|---|
author | Favié, Laurent M. A. Groenendaal, Floris van den Broek, Marcel P. H. Rademaker, Carin M. A. de Haan, Timo R. van Straaten, Henrica L. M. Dijk, Peter H. van Heijst, Arno Dudink, Jeroen Dijkman, Koen P. Rijken, Monique Zonnenberg, Inge A. Cools, Filip Zecic, Alexandra van der Lee, Johanna H. Nuytemans, Debbie H. G. M. van Bel, Frank Egberts, Toine C. G. Huitema, Alwin D. R. |
author_facet | Favié, Laurent M. A. Groenendaal, Floris van den Broek, Marcel P. H. Rademaker, Carin M. A. de Haan, Timo R. van Straaten, Henrica L. M. Dijk, Peter H. van Heijst, Arno Dudink, Jeroen Dijkman, Koen P. Rijken, Monique Zonnenberg, Inge A. Cools, Filip Zecic, Alexandra van der Lee, Johanna H. Nuytemans, Debbie H. G. M. van Bel, Frank Egberts, Toine C. G. Huitema, Alwin D. R. |
author_sort | Favié, Laurent M. A. |
collection | PubMed |
description | OBJECTIVE: Morphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study was to describe pharmacokinetics of morphine and its metabolites morphine-3-glucuronide and morphine-6-glucuronide in encephalopathic neonates treated with therapeutic hypothermia and to develop pharmacokinetics based dosing guidelines for this population. STUDY DESIGN: Term and near-term encephalopathic neonates treated with therapeutic hypothermia and receiving morphine were included in two multicenter cohort studies between 2008–2010 (SHIVER) and 2010–2014 (PharmaCool). Data were collected during hypothermia and rewarming, including blood samples for quantification of morphine and its metabolites. Parental informed consent was obtained for all participants. RESULTS: 244 patients (GA mean (sd) 39.8 (1.6) weeks, BW mean (sd) 3,428 (613) g, male 61.5%) were included. Morphine clearance was reduced under hypothermia (33.5°C) by 6.89%/°C (95% CI 5.37%/°C– 8.41%/°C, p<0.001) and metabolite clearance by 4.91%/°C (95% CI 3.53%/°C– 6.22%/°C, p<0.001) compared to normothermia (36.5°C). Simulations showed that a loading dose of 50 μg/kg followed by continuous infusion of 5 μg/kg/h resulted in morphine plasma concentrations in the desired range (between 10 and 40 μg/L) during hypothermia. CONCLUSIONS: Clearance of morphine and its metabolites in neonates is affected by therapeutic hypothermia. The regimen suggested by the simulations will be sufficient in the majority of patients. However, due to the large interpatient variability a higher dose might be necessary in individual patients to achieve the desired effect. TRIAL REGISTRATION: www.trialregister.nl NTR2529. |
format | Online Article Text |
id | pubmed-6375702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63757022019-03-01 Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia Favié, Laurent M. A. Groenendaal, Floris van den Broek, Marcel P. H. Rademaker, Carin M. A. de Haan, Timo R. van Straaten, Henrica L. M. Dijk, Peter H. van Heijst, Arno Dudink, Jeroen Dijkman, Koen P. Rijken, Monique Zonnenberg, Inge A. Cools, Filip Zecic, Alexandra van der Lee, Johanna H. Nuytemans, Debbie H. G. M. van Bel, Frank Egberts, Toine C. G. Huitema, Alwin D. R. PLoS One Research Article OBJECTIVE: Morphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study was to describe pharmacokinetics of morphine and its metabolites morphine-3-glucuronide and morphine-6-glucuronide in encephalopathic neonates treated with therapeutic hypothermia and to develop pharmacokinetics based dosing guidelines for this population. STUDY DESIGN: Term and near-term encephalopathic neonates treated with therapeutic hypothermia and receiving morphine were included in two multicenter cohort studies between 2008–2010 (SHIVER) and 2010–2014 (PharmaCool). Data were collected during hypothermia and rewarming, including blood samples for quantification of morphine and its metabolites. Parental informed consent was obtained for all participants. RESULTS: 244 patients (GA mean (sd) 39.8 (1.6) weeks, BW mean (sd) 3,428 (613) g, male 61.5%) were included. Morphine clearance was reduced under hypothermia (33.5°C) by 6.89%/°C (95% CI 5.37%/°C– 8.41%/°C, p<0.001) and metabolite clearance by 4.91%/°C (95% CI 3.53%/°C– 6.22%/°C, p<0.001) compared to normothermia (36.5°C). Simulations showed that a loading dose of 50 μg/kg followed by continuous infusion of 5 μg/kg/h resulted in morphine plasma concentrations in the desired range (between 10 and 40 μg/L) during hypothermia. CONCLUSIONS: Clearance of morphine and its metabolites in neonates is affected by therapeutic hypothermia. The regimen suggested by the simulations will be sufficient in the majority of patients. However, due to the large interpatient variability a higher dose might be necessary in individual patients to achieve the desired effect. TRIAL REGISTRATION: www.trialregister.nl NTR2529. Public Library of Science 2019-02-14 /pmc/articles/PMC6375702/ /pubmed/30763356 http://dx.doi.org/10.1371/journal.pone.0211910 Text en © 2019 Favié et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Favié, Laurent M. A. Groenendaal, Floris van den Broek, Marcel P. H. Rademaker, Carin M. A. de Haan, Timo R. van Straaten, Henrica L. M. Dijk, Peter H. van Heijst, Arno Dudink, Jeroen Dijkman, Koen P. Rijken, Monique Zonnenberg, Inge A. Cools, Filip Zecic, Alexandra van der Lee, Johanna H. Nuytemans, Debbie H. G. M. van Bel, Frank Egberts, Toine C. G. Huitema, Alwin D. R. Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title | Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title_full | Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title_fullStr | Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title_full_unstemmed | Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title_short | Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
title_sort | pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375702/ https://www.ncbi.nlm.nih.gov/pubmed/30763356 http://dx.doi.org/10.1371/journal.pone.0211910 |
work_keys_str_mv | AT favielaurentma pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT groenendaalfloris pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT vandenbroekmarcelph pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT rademakercarinma pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT dehaantimor pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT vanstraatenhenricalm pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT dijkpeterh pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT vanheijstarno pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT dudinkjeroen pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT dijkmankoenp pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT rijkenmonique pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT zonnenbergingea pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT coolsfilip pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT zecicalexandra pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT vanderleejohannah pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT nuytemansdebbiehgm pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT vanbelfrank pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT egbertstoinecg pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT huitemaalwindr pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia AT pharmacokineticsofmorphineinencephalopathicneonatestreatedwiththerapeutichypothermia |